Shares in pharmaceutical giant Aspen Pharmacare took a sharp dive in early trading on Friday. They slumped by as much as 15% after the company issued a profit warning for its financial year ending in June. The announcement cited significant impairments totalling R4.1 billion and increased restructuring costs as primary drivers for the expected drop in earnings. Consequently, the announcement…